Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -166,175 | -176,543 | 4,624 | 18,487 | 3,204 |
| Depreciation Amortization | 22,354 | 14,880 | 7,422 | 45,683 | 37,873 |
| Income taxes - deferred | -331 | -4,681 | -2,915 | -37,038 | -16,571 |
| Accounts receivable | 10,154 | 23,443 | 22,461 | -18,788 | 3,526 |
| Accounts payable and accrued liabilities | -4,468 | 458 | -1,184 | -2,772 | -4,094 |
| Other Working Capital | 601 | 30,154 | 33,646 | -32,840 | -2,906 |
| Other Operating Activity | 188,806 | 168,481 | -18,774 | 35,581 | 9,716 |
| Operating Cash Flow | $50,941 | $56,192 | $45,280 | $8,313 | $30,748 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -5,250 | -250 |
| PPE Investments | -170,068 | -170,019 | -350 | -1,226 | -1,219 |
| Other Investing Activity | -5,000 | 0 | 0 | 4,634 | -366 |
| Investing Cash Flow | $-175,068 | $-170,019 | $-350 | $-1,842 | $-1,835 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 290,495 | N/A |
| Debt Repayment | N/A | N/A | N/A | -269,913 | -36,332 |
| Common Stock Issued | 827 | 433 | 308 | 6,214 | 1,836 |
| Other Financing Activity | 99 | -114 | 0 | 43,737 | 17,676 |
| Financing Cash Flow | $926 | $319 | $308 | $70,533 | $-16,820 |
| Exchange Rate Effect | -66 | -66 | -66 | 13,020 | 8,088 |
| Beginning Cash Position | 198,308 | 198,308 | 198,308 | 108,284 | 108,284 |
| End Cash Position | 75,041 | 84,734 | 243,480 | 198,308 | 128,465 |
| Net Cash Flow | $-123,267 | $-113,574 | $45,172 | $90,024 | $20,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | 50,941 | 56,192 | 45,280 | 8,313 | 30,748 |
| Capital Expenditure | -170,068 | -170,019 | -350 | -1,226 | -1,219 |
| Free Cash Flow | -119,127 | -113,827 | 44,930 | 7,087 | 29,529 |